Yellow Dock

Western herbalism classifies yellow dock root first as an alterative, with mild laxative and bitter-tonic actions alongside.

It is given for chronic skin eruptions and eczema, and for constipation, haemorrhoids, a sluggish liver and poor digestion. The tradition treats these skin complaints as linked to sluggish elimination.

The Eclectic physicians used it in the same way, as a “blood purifier” and tonic in chronic inflammatory and debilitated states.

It is taken as a decoction or tincture of the root, usually in long-term formulas over several weeks rather than as a single laxative dose.

Folk practice adds anaemia, general weakness and use as a spring tonic. The young leaves are eaten as cooked greens.

In traditional Korean medicine the root is used for diseases of the spleen and the skin and for several inflammatory conditions ^{1Reference 1Eom et al. · 2020In vitroIn vitro antioxidant, anti-inflammation, and anticancer activities and anthraquinone content from Rumex crispus root extract and fractions — in vitro studyView study →}.

Known in Turkey as labada, yellow dock is used in folk medicine for gynaecological complaints, including postpartum complications and infertility ^{5Reference 5Süntar et al. · 2021AnimalPreventive effect of Rumex crispus L. on surgically induced intra-abdominal adhesion model in rats — animal modelView study →}.

The root contains roughly 3–4% anthraquinones, largely as glycosides, including emodin, chrysophanol, physcion and rhein ^{1,9Reference 1Eom et al. · 2020In vitroIn vitro antioxidant, anti-inflammation, and anticancer activities and anthraquinone content from Rumex crispus root extract and fractions — in vitro studyView study →Reference 9Vasas et al. · 2015ReviewThe genus Rumex: Review of traditional uses, phytochemistry and pharmacology — reviewView study →}. In the colon, gut bacteria cleave the glycosides to active aglycones, which stimulate peristalsis and fluid secretion. This is the same stimulant-laxative mechanism as senna and rhubarb ^{8,9Reference 8Qian et al. · 2024ReviewRumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety — reviewView study →Reference 9Vasas et al. · 2015ReviewThe genus Rumex: Review of traditional uses, phytochemistry and pharmacology — reviewView study →}.

Yellow dock is a comparatively mild member of that class, used traditionally as a gentle laxative and bitter digestive rather than a purgative ^{8Reference 8Qian et al. · 2024ReviewRumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety — reviewView study →}.

Gap: no clinical trial has tested yellow dock for constipation. The evidence is class pharmacology plus traditional use, and anthraquinone content varies with harvest and preparation.

In a fractionation of an ethanol root extract, the dichloromethane and ethyl-acetate fractions were richest in polyphenols and flavonoids. They showed the strongest free-radical scavenging, with positive FRAP, TEAC and ORAC results ^{1Reference 1Eom et al. · 2020In vitroIn vitro antioxidant, anti-inflammation, and anticancer activities and anthraquinone content from Rumex crispus root extract and fractions — in vitro studyView study →}.

A 2024 review lists antioxidant activity among the effects consistently reported for the plant ^{8Reference 8Qian et al. · 2024ReviewRumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety — reviewView study →}.

All of it comes from cell-free assays on enriched fractions. No study has measured antioxidant status in people taking the root.

In the same fractionation study, the ethyl-acetate fraction reduced nitric oxide and the inflammatory cytokines TNF-α, IL-1β and IL-6 in stimulated macrophage cells ^{1Reference 1Eom et al. · 2020In vitroIn vitro antioxidant, anti-inflammation, and anticancer activities and anthraquinone content from Rumex crispus root extract and fractions — in vitro studyView study →}.

In a related species, Rumex nepalensis, root extracts reduced ear oedema in mice and inhibited COX-1 and COX-2. Emodin and nepodin were among the active compounds ^{10Reference 10Gautam et al. · 2010In vitroAnti-inflammatory, cyclooxygenase (COX)-2, COX-1 inhibitory, and free radical scavenging effects of Rumex nepalensis — in vitro studyView study →}.

No in vivo anti-inflammatory study of R. crispus root and no human data exist.

Nepodin, a naphthalene derivative found in Rumex roots, stimulated glucose uptake in L6 muscle cells in a dose-dependent way. The effect was abolished by an AMPK inhibitor, and nepodin both activated AMPK and moved the GLUT4 glucose transporter to the cell membrane ^{4Reference 4Ha et al. · 2014In vitroAntidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivo — in vitro and mouse studyView study →}.

In db/db diabetic mice, nepodin lowered fasting glucose, improved glucose tolerance and restored AMPK activation in skeletal muscle ^{4Reference 4Ha et al. · 2014In vitroAntidiabetic effect of nepodin, a component of Rumex roots, and its modes of action in vitro and in vivo — in vitro and mouse studyView study →}.

Gap: no study links whole-root preparations to blood-sugar effects, and the nepodin content of a typical root preparation has not been measured.

Water-soluble compounds from R. crispus were screened against human colorectal adenocarcinoma (DLD-1) cells. The most potent fraction, L19, slowed cell growth in a dose-dependent way and induced apoptosis through caspase activation ^{2Reference 2Mohammadhosseinpour et al. · 2023In vitroAnti-proliferative and apoptotic activities of Rumex crispus — in vitro cell-line studyView study →}.

In the Eom fractionation study, the anthraquinone-rich dichloromethane fraction induced apoptosis in HepG2 liver cancer cells through p53 and caspase activation ^{1Reference 1Eom et al. · 2020In vitroIn vitro antioxidant, anti-inflammation, and anticancer activities and anthraquinone content from Rumex crispus root extract and fractions — in vitro studyView study →}.

Gap: these are cell-line studies only. There is no animal tumour model for R. crispus, and L19 is an uncharacterised fraction rather than a defined compound.

A 2026 study isolated fourteen compounds from the root and tested them in HepG2 cells loaded with fatty acids, a cell model of non-alcoholic fatty liver. Six compounds reduced fat accumulation by 71–81%. At 100 μM, the new flavan-3-ol–chromone compound also lowered cellular cholesterol, triglycerides, AST and ALT ^{6Reference 6Guo et al. · 2026In vitroA new flavonoid isolated from the roots of Rumex crispus L. with anti-NAFLD activity — in vitro studyView study →}.

A 2024 review lists liver-related activity among the plant’s reported effects ^{8Reference 8Qian et al. · 2024ReviewRumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety — reviewView study →}.

These are purified compounds in a liver cell line. There is no animal or human liver-outcome data for the root.

Bioassay-guided fractionation of a 70% ethanol extract of R. crispus identified nepodin as its antimalarial constituent ^{7Reference 7Lee et al. · 2013In vitroAntimalarial activity of nepodin isolated from Rumex crispus — in vitro and mouse studyView study →}.

Nepodin inhibited the Plasmodium falciparum enzyme PfNDH2, with IC50 values of 0.74 and 0.79 μg/mL against chloroquine-sensitive and chloroquine-resistant strains. In infected mice, doses of 10, 50 and 250 mg/kg suppressed parasitaemia by 97–99% and extended survival ^{7Reference 7Lee et al. · 2013In vitroAntimalarial activity of nepodin isolated from Rumex crispus — in vitro and mouse studyView study →}.

Gap: one study of one isolated compound. No evidence shows that any yellow dock preparation delivers nepodin at these levels, and malaria is not a traditional use of the herb.

In a rat model of surgically induced abdominal adhesions, aqueous-methanol extracts of the leaf, fruit and root were each placed once into the abdominal cavity at 100 mg/kg. The root extract was the most active. It reduced adhesion scores, inflammatory cytokines and inflammatory cells, and one of its fractions also reduced uterine fibrosis ^{5Reference 5Süntar et al. · 2021AnimalPreventive effect of Rumex crispus L. on surgically induced intra-abdominal adhesion model in rats — animal modelView study →}.

This is one rodent study with the extract placed directly in the abdomen, far from oral use, and it has not been replicated.

Compounds isolated from the root, including the new seco-anthraquinone crispuside A, mostly showed weak activity against three skin fungi. One known emodin-type anthraquinone was notably active, though less potent than the drug terbinafine ^{11Reference 11Li et al. · 2022In vitroNew seco-anthraquinone glucoside from the roots of Rumex crispus — in vitro studyView study →}.

Nepodin isolated from Rumex japonicus roots inhibited Candida albicans biofilm and hyphal growth without affecting free-floating cells, and inhibited mixed biofilms with Staphylococcus aureus or Acinetobacter baumannii ^{3Reference 3Lee et al. · 2019In vitroInhibition of biofilm formation by Candida albicans and polymicrobial microorganisms by nepodin — in vitro studyView study →}.

The antibiofilm results are for a purified constituent from a different Rumex species, with no whole-root or clinical confirmation.

Laxative excess. In excess the root causes abdominal cramping and diarrhoea. Prolonged stimulant-laxative use carries the risks of the class: bowel dependence and potassium loss ^{8,9Reference 8Qian et al. · 2024ReviewRumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety — reviewView study →Reference 9Vasas et al. · 2015ReviewThe genus Rumex: Review of traditional uses, phytochemistry and pharmacology — reviewView study →}.

Digoxin and diuretics. Potassium loss can increase the effect of cardiac glycosides such as digoxin and add to the potassium depletion of thiazide and loop diuretics. These cautions come from the pharmacology of anthraquinone laxatives; no interaction study of yellow dock itself has been done.

Oxalate. The root and leaves contain oxalic acid and oxalate salts, so people prone to kidney stones or with significant kidney impairment should use it with care ^{8,9Reference 8Qian et al. · 2024ReviewRumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety — reviewView study →Reference 9Vasas et al. · 2015ReviewThe genus Rumex: Review of traditional uses, phytochemistry and pharmacology — reviewView study →}. Eating large quantities of raw leaf is the higher oxalate exposure; the root is the medicinal part.

Thrombocytopenia. Allergic reactions to the plant are documented ^{8Reference 8Qian et al. · 2024ReviewRumex crispus L.: A comprehensive review on botany, traditional uses, phytochemistry, pharmacology, and safety — reviewView study →}. One published case describes a 38-year-old woman who developed severe symptomatic immune thrombocytopenia, with a platelet count of 5 K/µL, a week after drinking a herbal tea containing yellow dock and burdock ^{12Reference 12Latif et al. · 2022Case reportHerbal teas and thrombocytopenia: a curious case of yellow dock and burdock-induced thrombocytopenia — case reportView study →}.